Уважаемые коллеги, доброго времени суток! Представляем вам британское научное издание Rheumatic Disease Clinics of North America. Журнал имеет второй квартиль, издаётся в W.B. Saunders Ltd., его SJR за 2022 г. равен 0,88, импакт-фактор 2,032, печатный ISSN - 0889-857X, электронный - 1558-3163, предметная область Ревматология. Вот так выглядит обложка:
Редактором является Майкл Вейсман, контактные данные - michael.weisman@cshs.org.
Журнал информирует о последних тенденциях в ведении пациентов, держит в курсе новейших достижений и обеспечивает надежную основу для выбора вариантов лечения. Каждый выпуск (февраль, май, август и ноябрь) посвящен одной теме в ревматологии и публикуется под руководством опытного редактора. Темы включают остеоартрит, ревматоидный артрит, хрусталиковые заболевания, обследование MSK, заболевания костей, иммунодефицитные состояния, волчанку, нервно-мышечные заболевания, болевые расстройства, склеродермию, васкулит, педиатрию, терапию, рекомендации по лечению и методы его проведения.
Адрес издания - https://www.sciencedirect.com/journal/rheumatic-disease-clinics-of-north-america
Пример статьи, название - The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis. Заголовок (Abstract)
Giant cell arteritis diagnosis
Launched by the seminal publication by Schmidt and colleagues in 1997, data supporting the use of ultrasound in the diagnosis and monitoring of LVV have grown exponentially.15 Improvements in ultrasound technology and the use of high-frequency transducers (>15 MHz) have improved resolution and allowed for greater visualization of the intima-media complex (IMC) and associated vasculitic changes. Color Doppler is typically used to highlight the demarcation between the vessel wall and lumen.
Positron Emission Tomography for Large Vessel Vasculitis Diagnosis
Traditionally utilized in the field of oncology, PET/CT has gained expanded indications as technology and clinical experience have advanced. As a functional imaging technique, FDG-PET/CT detects elevated glucose uptake from the high glycolytic activity of inflammatory cells, such as those present in the vessel walls of patients with arteritis (Fig. 2).32 In cases of suspected GCA, PET/CT has shown high diagnostic accuracy for both large vessel and cranial disease. A prospective study of
Cranial giant cell arteritis
As noted above, EULAR recommends temporal artery ultrasound ( ± axillary arteries) as the first imaging modality in those with suspected cranial GCA.27 If ultrasound is not available or inconclusive, high-resolution MRI of the cranial arteries can be used to investigate mural inflammation and to assist with the diagnosis of GCA. In a prospective multicenter trial of 185 patients with GCA with clinical diagnosis serving as the gold standard (53% with TAB), the sensitivity of high-resolution MRI
Diagnosis of Large Vessel Vasculitis
Like MRI, vessel wall edema and mural enhancement on CT are signs of active vasculitis.55 Circumferential wall thickening with enhancement and the so called “double ring sign,” or edematous inner wall with enhancing outer wall on delayed contrast-enhanced images, are also suggestive of active inflammation (see Table 1).60CT can be used as an alternative imaging modality to MRI for the initial imaging test for TAK. One study examined the role of CTA compared with angiography and reported a
Angiography
Conventional angiography is no longer recommended in the diagnosis and monitoring of LVV.45 It cannot show early vasculitis lesions such as thickening of the vessel wall and therefore noninvasive imaging is recommended over catheter-based dye angiography to assess disease activity (see Table 1).13 Its role is primarily in guiding interventional procedures, but it involves exposure to ionizing radiation, requires invasive cannulation via femoral access, and carries a risk of complications,
Summary
Technological advances and increased recognition of the prevalence and implications of LVV have led to robust research into many imaging techniques. Although there is still debate about which modality to choose in various clinical scenarios, clinicians now have numerous options that are safe and noninvasive. Ultrasound, PET/CT, MR/A, and CT/A offer complementary information regarding diagnosis and disease activity. Future investigations will continue to highlight the strengths and limitations